Wilson Jason Douglas

CIK 00016623951 companyIRVING, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001662395

Recent Transactions

50 trades

Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2020-01-02+15,000→ 15,000 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$202.51/sh−3,400→ 17,750 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$207.48/sh−400→ 12,950 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-12-16$11.00/sh+10,000→ 28,827 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-12-16−5,600→ 13,227 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16+5,600→ 22,950 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$206.88/sh−400→ 13,350 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$200.17/sh−500→ 22,450 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-12-16−10,000→ 18,827 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$205.07/sh−200→ 13,750 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$201.65/sh−1,300→ 21,150 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$203.60/sh−2,320→ 15,430 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-12-16−10,000→ 34,881 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16+10,000→ 17,350 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-12-16$204.54/sh−1,480→ 13,950 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-11-11+17,250→ 17,250 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-17$170.00/sh−10,000→ 7,350 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-10-17−10,000→ 44,881 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-10-17−10,000→ 18,827 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-17+10,000→ 17,350 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-10-17$11.00/sh+10,000→ 28,827 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-15$148.46/sh−2,900→ 7,350 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-10-15−15,000→ 18,827 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-15$145.55/sh−11,800→ 10,550 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-15+15,000→ 22,350 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-15$146.61/sh−300→ 10,250 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-10-14−15,000→ 33,827 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-14+15,000→ 22,350 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-10-14$100.00/sh−15,000→ 7,350 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-10-14+17,250→ 17,250 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-10-10−5,181→ 8,700 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-10-10+5,181→ 48,827 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-09-12−7,350→ 43,646 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-09-12$11.62/sh+7,350→ 50,996 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-09-12+7,350→ 7,350 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-09-12−7,350→ 13,881 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-08-15−4,000→ 43,646 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-08-15$74.50/sh−100→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-08-15$11.00/sh+4,000→ 47,646 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-08-15+4,000→ 4,000 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-08-15−4,000→ 54,881 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-08-15$73.11/sh−1,772→ 100 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-08-15$72.25/sh−2,128→ 1,872 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-07-15−4,000→ 43,646 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-07-15$84.73/sh−989→ 1,200 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-07-15+4,000→ 4,000 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-07-15$11.00/sh+4,000→ 47,646 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-07-15$85.64/sh−1,200→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-07-15$83.93/sh−1,811→ 2,189 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-07-15−4,000→ 58,881 total

Companies

REATA PHARMACEUTICALS INC
See Remarks

Recent Filings

Address

2801 GATEWAY DRIVE, SUITE 150

IRVING, TX, 75063

View on SEC.gov